Publications in collaboration with researchers from Hospital Universitario 12 de Octubre (10)

2019

  1. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: Pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    Obstetrical and Gynecological Survey

2018

  1. Expression III: Patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries

    Annals of Oncology, Vol. 29, Núm. 4, pp. 910-916

  2. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    The Lancet Oncology, Vol. 19, Núm. 12, pp. 1680-1687

2012

  1. Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: A phase II study evaluating co-treatment with dexamethasone

    Investigational New Drugs, Vol. 30, Núm. 2, pp. 729-740

2010

  1. Advanced ovarian cancer: Phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel

    Journal of the National Cancer Institute, Vol. 102, Núm. 20, pp. 1547-1556

  2. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

    New England Journal of Medicine, Vol. 363, Núm. 10, pp. 943-953

2000

  1. Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer

    Clinical Cancer Research, Vol. 6, Núm. 6, pp. 2356-2362

  2. Doxorubicin and paclitaxel in advanced breast carcinoma: Importance of prior adjuvant anthracycline therapy

    Cancer, Vol. 89, Núm. 11, pp. 2169-2175

1998

  1. Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relatives

    International Journal of Oncology, Vol. 13, Núm. 2, pp. 275-279

1997

  1. Combination of oral idarubicin and prednimustine in advanced breast cancer: A phase II study

    European Journal of Cancer Part A, Vol. 33, Núm. 2, pp. 312-315